2SEVENTYBIO Trademark

Trademark Overview

On Wednesday, September 8, 2021, a trademark application was filed for 2SEVENTYBIO with the United States Patent and Trademark Office. The USPTO has given the 2SEVENTYBIO trademark a serial number of 97017422. The federal status of this trademark filing is FINAL REFUSAL - MAILED as of Tuesday, April 23, 2024. This trademark is owned by 2seventy bio, Inc.. The 2SEVENTYBIO trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Pharmaceutical research and development
2seventybio

General Information

Serial Number97017422
Word Mark2SEVENTYBIO
Filing DateWednesday, September 8, 2021
Status645 - FINAL REFUSAL - MAILED
Status DateTuesday, April 23, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateNOT AVAILABLE

Trademark Statements

Description of MarkThe mark consists of the stylized design of a number 7 comprised of an elongated upper triangle in green and an elongated lower triangle in green, with the stylized design of the 7 to the upper-right of "2SEVENTYBIO" in black stylized lowercase letters. The elongated upper triangle has a rounded point at its upper right, and its lower side is curved inwardly where it interfaces with the lower elongated triangle, which has a rounded point at its upper right. The letters "SEVENTY" are bolded relative to the number "2" and the letters "BIO".
Pseudo MarkTWO SEVENTY BIO
Indication of Colors claimedThe color(s) green and black is/are claimed as a feature of the mark.
Goods and ServicesPharmaceutical research and development

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateMonday, October 18, 2021
Primary Code042
First Use Anywhere DateTuesday, January 31, 2023
First Use In Commerce DateTuesday, January 31, 2023

Trademark Owner History

Party Name2seventy bio, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressCambridge, MA 02142

Trademark Events

Event DateEvent Description
Saturday, September 11, 2021NEW APPLICATION ENTERED
Monday, October 18, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, December 21, 2021ASSIGNED TO EXAMINER
Tuesday, October 19, 2021NOTICE OF DESIGN SEARCH CODE E-MAILED
Monday, January 3, 2022NON-FINAL ACTION WRITTEN
Monday, January 3, 2022NON-FINAL ACTION E-MAILED
Monday, January 3, 2022NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, June 30, 2022TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, June 30, 2022CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, July 1, 2022TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, July 22, 2022SUSPENSION LETTER WRITTEN
Friday, July 22, 2022LETTER OF SUSPENSION E-MAILED
Friday, July 22, 2022NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Wednesday, February 8, 2023NON-FINAL ACTION WRITTEN
Wednesday, February 8, 2023NON-FINAL ACTION E-MAILED
Wednesday, February 8, 2023NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, March 1, 2023SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Tuesday, May 2, 2023APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Tuesday, May 2, 2023APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Tuesday, August 8, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, August 8, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, August 8, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, April 23, 2024FINAL REFUSAL WRITTEN
Tuesday, April 23, 2024NOTIFICATION OF FINAL REFUSAL EMAILED
Friday, July 5, 2024APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Tuesday, October 15, 2024TEAS AMENDMENT OF USE RECEIVED
Tuesday, October 15, 2024USE AMENDMENT FILED
Tuesday, October 15, 2024AMENDMENT TO USE PROCESSING COMPLETE
Friday, July 5, 2024APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Tuesday, April 23, 2024FINAL REFUSAL E-MAILED

Related Keywords

seventybio development research pharmaceutical